Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Neurology | Family Medicine
Brain Cancer Clinical Trials
A listing of Brain Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
Arkansas
Little Rock : University of Arkansas for Medical Sciences
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
California
Duarte : City of Hope
A Phase II Clinical Trial Evaluating DCVax-Brain, Autologous Dendritic Cells Pulsed with Tumor Lysate Antigen for the Treatment of Glioblastoma Multiforme
Duarte : City of Hope
A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas
Duarte : City of Hope
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF with Adjuvant Temozolomide in Patients with Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma (The ACT IV Study)
Duarte : City of Hope
Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination with Interleukin-2
Duarte : City of Hope
RTOG 0929: A Randomized Phase I/II Study of ABT-888 in Combination with Temozolomide in Recurrent (Temozolomide Resistant) Glioblastoma
View More »
Duarte : City of Hope
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Irvine : UCI Medical Center
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
La Jolla : UCSD Moores Cancer Center
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Los Angeles : UCLA
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Newport Beach : Hoag Memorial Hospital Presbyterian
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Sacramento : Sutter Institute for Medical Research
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
San Francisco : University of California San Francisco
Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma
South Pasadena : South Pasadena Cancer Center
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Colorado
Aurora : University of Colorado Cancer Center
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
District of Columbia
Washington : Georgetown University Medical Center
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Florida
Miami Beach : Mount Sinai CCOP
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Sarasota : Florida Cancer Specialists Updated
Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma or Progressive Secondary Brain Tumor
Illinois
Elgin : Sherman Health
ECOG E3F05 Ph III RT + Temodar symptomatic/progress low grd glioma (astro, oligodendro, or oligastro) No pilocytic astro, gangioglioma, pleomorph xanthastro or dysembryoplastic neuorepithel. Supratentorial.
View More »
Chicago : Rush University Medical Center
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Chicago : University of Illinois Medical Center
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Peoria : Illinois Cancer Care
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Indiana
Indianapolis : IU Simon Cancer Center
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Massachusetts
Boston : Tufts Medical Center
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Michigan
Ann Arbor : University of Michigan, Department of Neurosurgery
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Detroit : Henry Ford Hospital
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Minnesota
Minneapolis : Virginia Piper Cancer Institute
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Missouri
Kansas City : St. Luke's Hospital
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
St. Louis : Washington University School of Medicine
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
New Jersey
Basking Ridge : Memorial Sloan-Kettering at Basking Ridge
EGFR Inhibition Using High Dose Administration of Erlotinib Weekly for Recurrent Malignant Gliomas With EGFR Variant III Mutation
Basking Ridge : Memorial Sloan-Kettering at Basking Ridge
Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma
Hackensack : John Theurer Cancer Center at Hackensack University Medical Center
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Summit : Overlook Hospital
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Summit : Overlook Hospital
Temodar (Temozolomide), Bevacizumab, Lithium and Radiation for High Grade Glioma
New York
Commack : Memorial Sloan-Kettering Cancer Center at Commack
EGFR Inhibition Using High Dose Administration of Erlotinib Weekly for Recurrent Malignant Gliomas With EGFR Variant III Mutation
Commack : Memorial Sloan-Kettering Cancer Center at Commack
Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma
Commack, Great Neck : Long Island Brain Tumor Centre at Neurological Surgery P.C.
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Huntington : Huntington Hospital
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Manhasset : North Shore University Hospital
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
View More »
Mineola : Winthrop University Hospital
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
New York : Memorial Sloan Kettering Cancer Center
EGFR Inhibition Using High Dose Administration of Erlotinib Weekly for Recurrent Malignant Gliomas With EGFR Variant III Mutation
New York : Columbia University Medical Center
EGFR Inhibition Using High Dose Administration of Erlotinib Weekly for Recurrent Malignant Gliomas With EGFR Variant III Mutation
New York : Memorial Sloan Kettering Cancer Center
Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma
New York : Columbia University Medical Center
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
New York : New York University Clinical Cancer Center
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
New York : New York University Clinical Cancer Center
Temodar (Temozolomide), Bevacizumab, Lithium and Radiation for High Grade Glioma
Oceanside : South Nassau Community Hospital
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Rochester : University of Rochester Medical Center
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Rockville Centre : Mercy Medical Center
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
White Plains : Brain and Spine Surgeons of New York and Northern Westchester Hospital
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
North Carolina
Chapel Hill : University of North Carolina
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Durham : Duke University Medical Center
Aloxi for Prevention of Acute and Delayed Chemotherapy Induced Nausea and Vomiting (CINV) in Malignant Glioma (MG) Patients Receiving Irinotecan With Bevacizumab
Ohio
Cincinnati : UC Cancer Institute
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Cleveland : University Hospitals of Cleveland
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Cleveland : Cleveland Clinic Foundation
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Rhode Island
Providence : Rhode Island Hospital
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
South Carolina
Tennessee
Nashville : Sarah Cannon Research Institute Updated
Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma or Progressive Secondary Brain Tumor
Nashville : Vanderbilt Ingram Cancer Center
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Nashville : St. Thomas Hospital
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Texas
Houston : S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2-1 Private In Children With Primary Malignant Brain Tumors
View More »
Dallas : Baylor Research Institute
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Houston : UT MD Anderson Cancer Center
Lacosamide for Seizure Prophylaxis in High-Grade Gliomas
Houston : UT MD Anderson Cancer Center
Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)
Washington
Seattle : Swedish Hospital Neuroscience Research
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer